Correlation Between Atos SE and Jazz Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Atos SE and Jazz Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atos SE and Jazz Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atos SE and Jazz Pharmaceuticals plc, you can compare the effects of market volatilities on Atos SE and Jazz Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atos SE with a short position of Jazz Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atos SE and Jazz Pharmaceuticals.
Diversification Opportunities for Atos SE and Jazz Pharmaceuticals
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Atos and Jazz is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Atos SE and Jazz Pharmaceuticals plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jazz Pharmaceuticals plc and Atos SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atos SE are associated (or correlated) with Jazz Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jazz Pharmaceuticals plc has no effect on the direction of Atos SE i.e., Atos SE and Jazz Pharmaceuticals go up and down completely randomly.
Pair Corralation between Atos SE and Jazz Pharmaceuticals
Assuming the 90 days horizon Atos SE is expected to generate 62.21 times more return on investment than Jazz Pharmaceuticals. However, Atos SE is 62.21 times more volatile than Jazz Pharmaceuticals plc. It trades about 0.11 of its potential returns per unit of risk. Jazz Pharmaceuticals plc is currently generating about 0.13 per unit of risk. If you would invest 66.00 in Atos SE on October 14, 2024 and sell it today you would lose (65.79) from holding Atos SE or give up 99.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Atos SE vs. Jazz Pharmaceuticals plc
Performance |
| Timeline |
| Atos SE |
| Jazz Pharmaceuticals plc |
Atos SE and Jazz Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Atos SE and Jazz Pharmaceuticals
The main advantage of trading using opposite Atos SE and Jazz Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atos SE position performs unexpectedly, Jazz Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jazz Pharmaceuticals will offset losses from the drop in Jazz Pharmaceuticals' long position.| Atos SE vs. COFCO Joycome Foods | Atos SE vs. Dave Busters Entertainment | Atos SE vs. Ubisoft Entertainment SA | Atos SE vs. Nexstar Media Group |
| Jazz Pharmaceuticals vs. T MOBILE INCDL 00001 | Jazz Pharmaceuticals vs. Shenandoah Telecommunications | Jazz Pharmaceuticals vs. TELECOM ITALIA | Jazz Pharmaceuticals vs. Charter Communications |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |